Announcing a fistful of Foundation $200,000 research grants, a small patient advocacy group has formed MPN Genetics to help bring new gene editing technologies to a rare blood cancer. mGEN is supported by an elite international group of blood cancer scientists and specialists.
http://ift.tt/1LCTJBg
http://ift.tt/1LCTJBg
No comments:
Post a Comment